Trial Profile
MEtabolic Therapy with Trimetazidine in Acute heart failure: an open pilot randomized trial (The METTA - PRAGUE 10 Trial).
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs Trimetazidine (Primary)
- Indications Acute heart failure; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms METTA
- 16 Aug 2011 New trial record